Christoffer Björn Rosenblad

Christoffer Björn Rosenblad, listed as board member, has filed trades across 2 companies (mainly through Finansinspektionen), most often in Xvivo Perfusion Aktiebolag and Sedana Medical AB (publ). Over a trading history stretching from 2 June 2017 to 29 July 2025, the count stands at 29 filings.

Both buying and selling appear: 8 purchases worth €70k, against 11 sales worth €926k. On balance, insiders were net sellers of €857k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2025 to date brings 2 purchases and no sales.

Half of the purchases are above €5,020 and half below. On 1 out of 6 purchases, another insider of the same company was buying within the same 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

The newest entry dates from 29 July 2025: an open-market purchase of €35k, in Xvivo Perfusion Aktiebolag. Half of the filings or more reach the Finansinspektionen feed on the day of the trade. The legal deadline for notifying a trade is three business days (MAR article 19). Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.